Poly ICLC: clinical trials recruiting now

3

Recruiting trials

15

Conditions studied

15

US states with sites

1

Countries

Phase breakdown

Phase 1 2 Phase 2 1

Conditions being studied

Condition	Trials
Anatomic Stage IV Breast Cancer AJCC v8	2
Breast cancer	2
Lung cancer	2
Melanoma	2
Clinical Stage IV Cutaneous Melanoma AJCC v8	1
Gastroesophageal Adenocarcinoma	1
Invasive Breast Carcinoma	1
Locally Advanced Cutaneous Melanoma	1
Locally Advanced Mucosal Melanoma	1
Metastatic Acral Melanoma	1
Metastatic Conjunctival Melanoma	1
Metastatic Cutaneous Melanoma	1
Metastatic HER2-Negative Breast Carcinoma	1
Metastatic Hormone Receptor-Positive Breast Carcinoma	1
Metastatic Lung Non-Small Cell Carcinoma	1

Recruiting trials involving Poly ICLC

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
NCT06529822 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
NCT05098210 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
NCT03606967 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations

Common questions

How many recruiting trials involve Poly ICLC?

3 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.